Dr. Prashant Kumar

Assistant Professor

Amity Institute Of Virology & Immunology

Medical Virology
Amity Institute of Virology and Immunology (AIVI)

Amity University, Sector-125, Noida

PhD: (2012) Faculty of Medical Sciences, University of Delhi, Delhi
7 Years
Introductory Virology; Essentials of Molecular Biology; Recombinant DNA Technology & Proteomics; Systematic Virology; Applied Virology; Viral Disease Management; Applied Genetics; Genome Engineering and Editing; Essentials of Biochemistry
Development of Immunogens and Antiviral Therapeutics
Virology; Molecular Biology; Immunology
02
Assistant Professor: February 2012 till date at Amity Institute of Virology & Immunology

Membership in:
American Society of Microbiology
Indian Immunological Society
Influenza Foundation of India
Toor D, Wasson M, Kumar P, Kaushik N, Karthikeyan G, Chavi Goel C, Singh Sandhya S, Kumar A, Prakash H. Dysbiosis disrupts Gut Immune homeostasis and Promote Gastric Diseases. (Accepted in IJMS in April 2019).
Rajput R, Khanna M, Kumar P, Kumar B, Sharma S, Gupta N, et al. Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice. Nucleic Acid Ther. 2012 Dec; 22(6):414-22.
Pati DR, Khanna M, Kumar B, Kumar P, Rajput R, Saxena L, Sharvani, Gaur SN. Clinical presentation of patients with seasonal influenza and pandemic influenza A (H1N1-2009) requiring hospitalisation. Indian J Chest Dis Allied Sci. 2013 Jan-Mar; 55(1):15-19.
Kumar P. Betel Leaf: A Source of Ingredients having Potential to Combat Influenza. Acta Scientific Microbiology. 2018 June; 1(6): 70-71.
Kumar P, Srivastava M. Prophylactic and Therapeutic approaches for Human Metapneumovirus. Virus Disease. 2018; DOI: 10.1007/s13337-018-0498-5.
Kumar P, Sood V, Vyas R, Gupta N, Banerjea AC, Khanna M. Potent inhibition of influenza virus replication with novel siRNA-chimericribozyme constructs. Antivir Res. 2010 Aug; 87(2):204-212.
Kumar P, Kumar B, Rajput R, Saxena L, Banerjea AC, Khanna M. Cross-Protective Effect of Antisense Oligonucleotide Developed Against the Common 3' NCR of Influenza A Virus Genome. Mol Biotechnol. 2013 Nov; 55(3):203-11.
Kumar P, Kumar B, Gupta A, Sharma B, Vijayan VK, Khare S, et al. Diagnosis of novel pandemic influenza virus (H1N1) 2009 in hospitalized patients. Indian J Virol. 2010 June; 21(1):45-49.
Kumar P, Khanna M, Kumar B, Banerjea AC. A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge. Antivir Res. 2012 Jan; 93(1): 78-85.
Kumar B, Pati DR, Khanna M, Kumar P, Daga MK, Singh V, et al. Age-sex distribution and seasonality pattern among influenza virus infected patients in Delhi, 2009-2010. Ind J Com Med. 2012 March; 37:57-58.
Kumar B, Kumar P, Rajput R, Saxena L, Daga MK, Khanna M. Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication. Nucleic Acid Ther. 2013 Oct; 23(5):355-62.
Kumar B, Kumar P, Rajput R, Daga MK, Singh V, Khanna M. Comparative reproducibility of SYBR Green I and TaqMan real-time PCR chemistries for the analysis of matrix and hemagglutinin genes of Influenza A viruses. Int J Collab Res Internal Med Public Health. 2012 Aug; 4(7):1346-1352
Kumar B, Khanna M, Kumar P, Sood V, Vyas R, Banerjea AC. Nucleic acid mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site. Mol Biotechnol. 2011 May; 51(1):27-36.
Kumar B, Khanna M, Kumar P, Gupta A, Daga MK, Sarkar MC, et al. Quantification of viral load in clinical specimens collected from different body sites of patients infected with influenza viruses. Int J Med Med Sci. 2011 May; 3(5):144-148.
Kumar P, Khanna M, Kumar B, Manocha N, Saini S, Deengar A. Epidemiological Review of Pandemic Influenza A (H1N1) Virus. Virology & Retrovirology Journal. 2019; 2(1):117
Khanna M, Rajput R, Kumar P, Sharma D, Mathur D, Prasad AK. Potent inhibition of pandemic influenza H1N1 (2009) virus propagation by novel chemically synthesized compounds. Influenza Other Respi Viruses .2011; 5(Suppl.1): 90-123.
Khanna M, Kumar P, Chaudhary K, Kumar B, Vijayan VK. Emerging influenza virus: a global threat. J Biosci. 2008 Nov; 33(4): 475-482.
Khanna M, Kumar B, Gupta N, Kumar P, Vijayan V K, Kaur H. Pandemic swine influenza virus (H1N1): a threatening evolution. Indian J Microbiol. 2009 Dec; 49:365-369.
Khanna M, Kumar B, Gupta A, Kumar P. Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future. Indian J Virol. 2012; 23(1):12-17.
Khanna M, Akther N, Srivastava V, Kumar P, Vijayan VK. Biological and epidemiological aspects of influenza virus H5N1 in context of India. Indian J Exp Biol. 2006 April; 44(4):265.
Asha K, Kumar P, Sanicas M, Meseko CA, Khanna M, Kumar B. Advancements in nucleic acid based therapeutics against respiratory viral infections. Journal of Clinical Medicine. 2019; DOI: 10.3390/jcm8010006.
Awards & Honors:
• Awarded “Young Scientist Presentation Prize” in National Symposium organized by Association of Clinical Biochemistry of India at Sir Ganga Ram Hospital, Delhi on 21st January 2012.
• Awarded International Travel Grant by DBT, Govt. of India to present my work in the Keystone symposia entitled “Pathogenesis of Influenza: Virus- Host Interactions” held at Hong Kong, China between 23-28th May 2011
• Selected for AGD prize in the “4th DITAN INTERNATIONAL CONFERENCE ON INFECTIOUS DISEASE” held at Beijing China between 15-18th July 2010.
• Awarded Junior Research Fellowship (JRF)-National Eligibility Test (NET) organized jointly by University Grant Commission (UGC) and Council of Scientific and Industrial Research (CSIR), Govt. of India, in December, 2004 which provided me to work in one of the premier institute of India for pursuing research work.
• Awarded Junior Research Fellowship (JRF) from Department of Biotechnology (DBT), Government of India in May 2005
Amity Institute of Virology and Immunology (AIVI)
Amity University, Sector-125, Noida